We are a leading international company offering end-to-end solutions ranging from the automation, process engineering and validation of biotech and pharmaceutical plants. With more than two decades of experience in GMP environments, we have in-depth knowledge of the applicable regulations.  

Hippocrates Research Swiss offers a boutique CRO model built on 30 years of experience. With a lean, agile structure and senior-level involvement, we transform scientific innovation into strong clinical assets, delivering capital efficiency, strategic focus, and measurable value.

Strategic Board & Transaction Advisory for Life Sciences Dr. Claudia Ulbrich advises growth-stage biotech and medtech companies as an independent board member and strategic advisor. She has more than 25 years experience as CEO, board member and advisor in private and public companies.